Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H McGovern

Showing results (71-80 of 103) with videos related to

Pageof 11
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 4, 2009
Improving the diagnosis of acute hepatitis C virus infection with expanded viral load criteriaBarbara H McGovern, Christopher E Birch, Melinda J Bowen, et al.
The Journal of Infectious Diseases|August 14, 2009
Rate of sustained virologic response in relation to baseline hepatitis C virus (HCV) RNA level and rapid virologic clearance in persons with acute HCV infectionBarbara H McGovern, Ellen H Nagami, Christopher E Birch, et al.
Open Forum Infectious Diseases|September 26, 2022
Manufacturing Process of SER-109, a Purified Investigational Microbiome Therapeutic, Reduces Risk of Coronavirus Transmission From Donor StoolChristopher McChalicher, Ahmad Abdulaziz, S Steve Zhou, et al.
Journal of Pediatric Surgery|December 1, 1972
Management of the severely obstructed urinary tract in the pediatric patient--a panel discussionT D Allen, J F Glenn, W H Hendren, et al.
Resuscitation|March 26, 2013
Rapid epinephrine administration improves early outcomes in out-of-hospital cardiac arrestC Koscik, A Pinawin, H McGovern, et al.
Gut Microbes|September 18, 2024
End-to-end donor screening and manufacturing controls: complementary quality-based strategies to minimize patient risk for donor-derived microbiome therapeuticsJason Goldsmith, Sarah Tomkovich, John G Auniņš, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 18, 2006
Acute hepatitis C virus infection in incarcerated injection drug usersBarbara H McGovern, Alysse Wurcel, Arthur Y Kim, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 31, 2007
Managing symptomatic drug-induced liver injury in HIV-hepatitis C virus-coinfected patients: a role for interferonBarbara H McGovern, Christopher Birch, M Tauheed Zaman, et al.
Topics in Antiviral Medicine|April 19, 2013
Impact of new therapeutics for hepatitis C virus infection in incarcerated populationsAnne S Spaulding, Arthur Y Kim, Amy Jo Harzke, et al.
The Journal of Infectious Diseases|August 4, 2023
Manufacturing Processes of a Purified Microbiome Therapeutic Reduce Risk of Transmission of Potential Bacterial Pathogens in Donor StoolChristopher W J McChalicher, Mary-Jane Lombardo, Sahil Khanna, et al.
Pageof 11

Showing results (71-80 of 103) with videos related to

Sort By:
Pageof 11
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 4, 2009
Improving the diagnosis of acute hepatitis C virus infection with expanded viral load criteriaBarbara H McGovern, Christopher E Birch, Melinda J Bowen, et al.
The Journal of Infectious Diseases|August 14, 2009
Rate of sustained virologic response in relation to baseline hepatitis C virus (HCV) RNA level and rapid virologic clearance in persons with acute HCV infectionBarbara H McGovern, Ellen H Nagami, Christopher E Birch, et al.
Open Forum Infectious Diseases|September 26, 2022
Manufacturing Process of SER-109, a Purified Investigational Microbiome Therapeutic, Reduces Risk of Coronavirus Transmission From Donor StoolChristopher McChalicher, Ahmad Abdulaziz, S Steve Zhou, et al.
Journal of Pediatric Surgery|December 1, 1972
Management of the severely obstructed urinary tract in the pediatric patient--a panel discussionT D Allen, J F Glenn, W H Hendren, et al.
Resuscitation|March 26, 2013
Rapid epinephrine administration improves early outcomes in out-of-hospital cardiac arrestC Koscik, A Pinawin, H McGovern, et al.
Gut Microbes|September 18, 2024
End-to-end donor screening and manufacturing controls: complementary quality-based strategies to minimize patient risk for donor-derived microbiome therapeuticsJason Goldsmith, Sarah Tomkovich, John G Auniņš, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 18, 2006
Acute hepatitis C virus infection in incarcerated injection drug usersBarbara H McGovern, Alysse Wurcel, Arthur Y Kim, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 31, 2007
Managing symptomatic drug-induced liver injury in HIV-hepatitis C virus-coinfected patients: a role for interferonBarbara H McGovern, Christopher Birch, M Tauheed Zaman, et al.
Topics in Antiviral Medicine|April 19, 2013
Impact of new therapeutics for hepatitis C virus infection in incarcerated populationsAnne S Spaulding, Arthur Y Kim, Amy Jo Harzke, et al.
The Journal of Infectious Diseases|August 4, 2023
Manufacturing Processes of a Purified Microbiome Therapeutic Reduce Risk of Transmission of Potential Bacterial Pathogens in Donor StoolChristopher W J McChalicher, Mary-Jane Lombardo, Sahil Khanna, et al.
Pageof 11